Literature DB >> 32804442

Monocyte Subsets With High Osteoclastogenic Potential and Their Epigenetic Regulation Orchestrated by IRF8.

Amitabh Das1,2, Xiaobei Wang1,2, Jessica Kang1, Alyssa Coulter2, Amol C Shetty3, Mahesh Bachu4,5, Stephen R Brooks6, Stefania Dell'Orso6, Brian L Foster7, Xiaoxuan Fan8, Keiko Ozato4, Martha J Somerman2, Vivek Thumbigere-Math1,2.   

Abstract

Osteoclasts (OCs) are bone-resorbing cells formed by the serial fusion of monocytes. In mice and humans, three distinct subsets of monocytes exist; however, it is unclear if all of them exhibit osteoclastogenic potential. Here we show that in wild-type (WT) mice, Ly6Chi and Ly6Cint monocytes are the primary source of OC formation when compared to Ly6C- monocytes. Their osteoclastogenic potential is dictated by increased expression of signaling receptors and activation of preestablished transcripts, as well as de novo gain in enhancer activity and promoter changes. In the absence of interferon regulatory factor 8 (IRF8), a transcription factor important for myelopoiesis and osteoclastogenesis, all three monocyte subsets are programmed to display higher osteoclastogenic potential. Enhanced NFATc1 nuclear translocation and amplified transcriptomic and epigenetic changes initiated at early developmental stages direct the increased osteoclastogenesis in Irf8-deficient mice. Collectively, our study provides novel insights into the transcription factors and active cis-regulatory elements that regulate OC differentiation.
© 2020 American Society for Bone and Mineral Research (ASBMR). © 2020 American Society for Bone and Mineral Research (ASBMR).

Entities:  

Keywords:  BONE MARROW; ChIP-seq; IRF8; LY6C; MACROPHAGE; MONOCYTE; OSTEOCLAST; RANK; RANKL; RNA-seq

Mesh:

Substances:

Year:  2020        PMID: 32804442      PMCID: PMC8168257          DOI: 10.1002/jbmr.4165

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  71 in total

1.  Cutting edge: IFN consensus sequence binding protein/IFN regulatory factor 8 drives the development of type I IFN-producing plasmacytoid dendritic cells.

Authors:  Hideki Tsujimura; Tomohiko Tamura; Keiko Ozato
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

Review 2.  Transcriptional regulation by Polycomb group proteins.

Authors:  Luciano Di Croce; Kristian Helin
Journal:  Nat Struct Mol Biol       Date:  2013-10       Impact factor: 15.369

3.  Identification and characterization of a novel monocyte subpopulation in human peripheral blood.

Authors:  B Passlick; D Flieger; H W Ziegler-Heitbrock
Journal:  Blood       Date:  1989-11-15       Impact factor: 22.113

4.  IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools.

Authors:  Jianxun Feng; Hongsheng Wang; Dong-Mi Shin; Marek Masiuk; Chen-Feng Qi; Herbert C Morse
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

Review 5.  Murine Monocytes: Origins, Subsets, Fates, and Functions.

Authors:  Alexander Mildner; Goran Marinkovic; Steffen Jung
Journal:  Microbiol Spectr       Date:  2016-10

Review 6.  Osteoclast precursors, RANKL/RANK, and immunology.

Authors:  Lianping Xing; Edward M Schwarz; Brendan F Boyce
Journal:  Immunol Rev       Date:  2005-12       Impact factor: 12.988

7.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2.

Authors:  Natalya V Serbina; Eric G Pamer
Journal:  Nat Immunol       Date:  2006-02-05       Impact factor: 25.606

8.  A novel mouse model of inflammatory bowel disease links mammalian target of rapamycin-dependent hyperproliferation of colonic epithelium to inflammation-associated tumorigenesis.

Authors:  Lin Deng; Jin-Feng Zhou; Rani S Sellers; Jiu-Feng Li; Andrew V Nguyen; Yubao Wang; Amos Orlofsky; Qiang Liu; David A Hume; Jeffrey W Pollard; Leonard Augenlicht; Elaine Y Lin
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

9.  Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis.

Authors:  Nikolaus B Binder; Birgit Niederreiter; Oskar Hoffmann; Richard Stange; Thomas Pap; Thomas M Stulnig; Matthias Mack; Reinhold G Erben; Josef S Smolen; Kurt Redlich
Journal:  Nat Med       Date:  2009-03-29       Impact factor: 53.440

10.  Non-classical monocytes as mediators of tissue destruction in arthritis.

Authors:  Antonia Puchner; Victoria Saferding; Michael Bonelli; Yohei Mikami; Melanie Hofmann; Julia S Brunner; Michael Caldera; Eliana Goncalves-Alves; Nikolaus B Binder; Anita Fischer; Elisabeth Simader; Carl-Walter Steiner; Harald Leiss; Silvia Hayer; Birgit Niederreiter; Thomas Karonitsch; Marije I Koenders; Bruno K Podesser; John J O'Shea; Jörg Menche; Josef S Smolen; Kurt Redlich; Stephan Blüml
Journal:  Ann Rheum Dis       Date:  2018-06-29       Impact factor: 19.103

View more
  3 in total

1.  The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice.

Authors:  Zamzam Awida; Almog Bachar; Hussam Saed; Anton Gorodov; Nathalie Ben-Califa; Maria Ibrahim; Albert Kolomansky; Jennifer Ana Iden; Liad Graniewitz Visacovsky; Tamar Liron; Sahar Hiram-Bab; Michael Brines; Yankel Gabet; Drorit Neumann
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

2.  Pseudolaric Acid B Attenuates High Salt Intake-Induced Hypertensive Left Ventricular Remodeling by Modulating Monocyte/Macrophage Phenotypes.

Authors:  Fang-Fang Yu; Guo-Hong Yang; Shao-Bo Chen; Xiu-Long Niu; Wei Cai; Yan-Yan Tao; Xiu-Juan Wang; Ming Li; Yu-Ming Li; Ji-Hong Zhao
Journal:  Med Sci Monit       Date:  2021-09-08

Review 3.  Epigenetic Regulators Involved in Osteoclast Differentiation.

Authors:  Kristina Astleford; Emily Campbell; Andrew Norton; Kim C Mansky
Journal:  Int J Mol Sci       Date:  2020-09-25       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.